Actively Recruiting
Pilot Trial Evaluating Semaglutide with Nicotine Replacement Therapy for Smoking Cessation in Adults with Type 2 Diabetes
Led by Ottawa Heart Institute Research Corporation · Updated on 2026-09-08
100
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether semaglutide, a medication primarily used for diabetes management, can help people with type 2 diabetes quit smoking when added to combination nicotine replacement therapy NRT. This pilot randomized controlled trial aims to explore the feasibility of conducting a larger study to evaluate semaglutides role in supporting smoking cessation and addressing weight gain after quitting. The study focuses on adults living with diabetes who smoke and examines preliminary outcomes like recruitment success and treatment adherence. Participants will be randomly assigned to one of two groups one receiving semaglutide plus combination NRT, and the other receiving combination NRT alone. Semaglutide dosing starts at 0.25 mg once weekly for 4 weeks, increasing to 0.5 mg, with a possible increase up to 2 mg weekly for additional blood sugar control. Both interventions will be used for up to 26 weeks 6 months to support smoking cessation efforts. During the study, participants will have regular assessments including smoking status, blood glucose levels, height, weight, and waist circumference at 6 and 12 months. The main outcome is project success at 12 months, with secondary outcomes including smoking status and metabolic measures. The study monitors treatment effects and participant well-being over a year, with follow-up visits to track progress and safety.
CONDITIONS
Brief Title
Semaglutide for Smoking Cessation in Patients With Diabetes
Research Team
E
Evyanne Quirouette
N
Nidhi Agrawal
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here